AAAAAA
Results: 1-25/62
Authors:
Heinzer, H
Huland, E
Huland, H
Citation: H. Heinzer et al., Systemic chemotherapy and chemoimmunotherapy for metastatic renal cell cancer, WORLD J URO, 19(2), 2001, pp. 111-119
Authors:
Noldus, J
Michl, U
Graefen, M
Haese, A
Hammerer, P
Fernandez, S
Huland, H
Citation: J. Noldus et al., Nerve-sparing radical retropublic prostatectomy. Outcome analysis based onpatient questionnaires, UROLOGE A, 40(2), 2001, pp. 102
Authors:
Hautmann, SH
Schroeder, GL
Civantos, F
Duncan, RC
Gnann, R
Friedrich, MG
Hellstern, A
Huland, H
Solowaym, MS
Lokeshwar, VB
Citation: Sh. Hautmann et al., Hyaluronic acid and hyaluronidase. Two new markers for bladder cancer, UROLOGE A, 40(2), 2001, pp. 121-126
Authors:
Reek, C
Conrad, S
Heinzer, H
Huland, H
Citation: C. Reek et al., Long-term follow-up after side-fire laser coagulation of the prostate withthe neodymium : YAG laser, UROLOGE A, 40(2), 2001, pp. 127-132
Authors:
Bangma, CH
Huland, H
Schroder, FH
van Cangh, PJ
Citation: Ch. Bangma et al., Early diagnosis and treatment of localized prostate cancer, EUR UROL, 40(3), 2001, pp. 1-10
Authors:
Huland, H
Citation: H. Huland, Latent Prostatic Carcinoma - Epidemiology - Biology - Clinical Significance - Detection and Prevention - 7th Symposium - Hamburg, November 2-4, 2000 - Abstracts, EUR UROL, 39, 2001, pp. 1-1
Authors:
Conrad, S
Hautmann, SH
Henke, RP
Erbersdobler, A
Simon, J
Straub, M
Graefen, M
Hautmann, RE
Huland, H
Citation: S. Conrad et al., Detection and characterization of early prostate cancer by six systematic biopsies and fine needle aspiration cytology in prostates from bladder cancer patients, EUR UROL, 39, 2001, pp. 25-29
Authors:
Prange, W
Erbersdobler, A
Hammerer, P
Graefen, M
Hautmann, SH
Hautmann, RE
Huland, H
Henke, RP
Citation: W. Prange et al., High-grade prostatic intraepithelial neoplasia in cystoprostatectomy specimens, EUR UROL, 39, 2001, pp. 30-31
Authors:
Shurin, GV
Aalamian, M
Pirtskhalaishvili, G
Bykovskaia, S
Huland, E
Huland, H
Shurin, MR
Citation: Gv. Shurin et al., Human prostate cancer blocks the generation of dendritic cells from CD34+hematopoietic progenitors, EUR UROL, 39, 2001, pp. 37-40
Authors:
Friedrich, MG
Riethdorf, S
Erbersdobler, A
Tiemer, C
Schwaibold, H
Solter, JK
Huland, E
Riethdorf, L
Conrad, S
Hammerer, PG
Huland, H
Citation: Mg. Friedrich et al., Relevance of p53 gene alterations for tumor recurrence in patients with superficial transitional cell carcinoma of the bladder, EUR UROL, 39(2), 2001, pp. 159-166
Authors:
Huland, H
Citation: H. Huland, Radical prostatectomy: Options and issues, EUR UROL, 39, 2001, pp. 3-9
Authors:
Haese, A
Graefen, M
Steuber, T
Becker, C
Pettersson, K
Piironen, T
Noldus, J
Huland, H
Lilja, H
Citation: A. Haese et al., Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml, PROSTATE, 49(2), 2001, pp. 101-109
Authors:
Aalamian, M
Pirtskhalaishvili, G
Nunez, A
Esche, C
Shurin, GV
Huland, E
Huland, H
Shurin, MR
Citation: M. Aalamian et al., Human prostate cancer regulates generation and maturation of monocyte-derived dendritic cells, PROSTATE, 46(1), 2001, pp. 68-75
Authors:
Prange, W
Erbersdobler, A
Hammerer, P
Graefen, M
Hautmann, SH
Hautmann, RE
Huland, H
Henke, RP
Citation: W. Prange et al., Significance of high-grade prostatic intraepithelial neoplasia in needle biopsy specimens, UROLOGY, 57(3), 2001, pp. 486-490
Authors:
Huland, H
Citation: H. Huland, Validity of the prostate specific antigen test for prostate cancer screening: Followup study with a bank of 21,000 sera in Finland - Comment, J UROL, 166(6), 2001, pp. 2191-2192
Authors:
Graefen, M
Haese, A
Pichlmeier, U
Hammerer, PG
Noldus, J
Butz, K
Erbersdobler, A
Henke, RP
Michl, U
Fernandez, S
Huland, H
Citation: M. Graefen et al., A validated strategy for side specific prediction of organ confined prostate cancer: A tool to select for nerve sparing radical prostatectomy, J UROL, 165(3), 2001, pp. 857-863
Authors:
Reek, C
Conrad, S
Tenschert, W
Huland, H
Citation: C. Reek et al., Do serum C-reactive protein measurements help to discriminate episodes of renal dysfunction in patients after renal transplantation?, CLIN CHIM A, 310(1), 2001, pp. 57-61
Authors:
Friedrich, MG
Evans, D
Noldus, J
Huland, H
Citation: Mg. Friedrich et al., The correction of penile curvature with the Essed-Schroder technique: a long-term follow-up assessing functional aspects and quality of life, BJU INT, 86(9), 2000, pp. 1034-1038
Authors:
Huland, E
Heinzer, H
Huland, H
Citation: E. Huland et al., Overview of interleukin-2 inhalation therapy, CA J SCI AM, 6, 2000, pp. S104-S112
Authors:
Friedrich, MG
Noldus, J
Fernandez, S
Huland, H
Citation: Mg. Friedrich et al., Correction of penile curvature with the Schroder-Essed technique: long-term follow-up considering functional aspects and life quality, UROLOGE A, 39(5), 2000, pp. 440-445
Authors:
Hammerer, P
Graefen, M
Steuber, T
Huland, H
Citation: P. Hammerer et al., Chemoprevention of prostate cancer, UROLOGE A, 39(4), 2000, pp. 304-308
Authors:
Heinzer, H
Huland, E
Huland, H
Citation: H. Heinzer et al., Treatment of metastatic renal cell carcinoma. Immunotherapy versus surgical removal, UROLOGE A, 39(4), 2000, pp. 356-361
Authors:
Huland, H
Heinzer, H
Steinbach, F
Citation: H. Huland et al., Commentary - Pros and cons regarding metastatic surgery - Is there still aplace for metastatic surgery in the treatment of metastasized renal cell carcinoma?, UROLOGE A, 39(4), 2000, pp. 367-367
Authors:
Graefen, M
Hammerer, P
Haese, A
Huland, H
Citation: M. Graefen et al., Therapy options for hormon-refractory carcinoma of the prostate, UROLOGE A, 39(3), 2000, pp. 267-273
Authors:
Huland, H
Wirth, M
Citation: H. Huland et M. Wirth, Prostate cancer, UROLOGE A, 39(1), 2000, pp. 2-2